Stay updated on DTX401 in Adults With GSDIa: Safety & Dose Clinical Trial
Sign up to get notified when there's something new on the DTX401 in Adults With GSDIa: Safety & Dose Clinical Trial page.

Latest updates to the DTX401 in Adults With GSDIa: Safety & Dose Clinical Trial page
- ChecktodayChange DetectedA banner announces NIH website transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check7 days agoChange DetectedThe site footer now identifies the platform as revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the study details view. This indicates restricted access to the study record on ClinicalTrials.gov.SummaryDifference19%

- Check49 days agoChange DetectedNo textual changes are recorded; the page content remains as previously displayed.SummaryDifference0.1%

- Check56 days agoChange DetectedA new NIH grant/contract entry for 2016 was added to the study identifiers, and the page footer now reflects Revision: v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

Stay in the know with updates to DTX401 in Adults With GSDIa: Safety & Dose Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DTX401 in Adults With GSDIa: Safety & Dose Clinical Trial page.